N'-Formylkynurenine

From WikiMD's Medical Encyclopedia

Revision as of 20:46, 30 December 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


A chemical compound related to tryptophan metabolism


Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

N'-Formylkynurenine is an intermediate in the metabolism of the essential amino acid tryptophan. It is formed by the action of the enzyme indoleamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO) on tryptophan, leading to the production of kynurenine pathway metabolites.

Biological Role[edit]

N'-Formylkynurenine plays a crucial role in the kynurenine pathway, which is the primary route of tryptophan catabolism in mammals. This pathway is involved in the production of several bioactive metabolites, including kynurenic acid, quinolinic acid, and nicotinamide adenine dinucleotide (NAD+).

Enzymatic Conversion[edit]

The conversion of tryptophan to N'-formylkynurenine is catalyzed by the enzymes IDO and TDO. These enzymes incorporate molecular oxygen into the indole ring of tryptophan, resulting in the formation of N'-formylkynurenine. This reaction is the first and rate-limiting step in the kynurenine pathway.

Clinical Significance[edit]

Alterations in the kynurenine pathway, including changes in the levels of N'-formylkynurenine, have been associated with various diseases, such as neurodegenerative disorders, cancer, and immune system dysfunctions. The pathway's metabolites can influence neurotransmission, immune response, and cellular energy metabolism.

Research and Applications[edit]

Research into N'-formylkynurenine and the kynurenine pathway is ongoing, with potential applications in developing therapeutic strategies for diseases linked to tryptophan metabolism. Modulating the activity of IDO and TDO, and thereby altering the levels of N'-formylkynurenine and other kynurenine pathway metabolites, is a promising area of study.

See Also[edit]

References[edit]

<references />

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.